ÂÜÀòÂÒÂ×

Dan is a scientist and entrepreneur focused on precision medicine in oncology. He is the co-founder and CEO of Strata Oncology, a venture-backed precision oncology company committed to accelerating the impact of precision medicine for patients with cancer.

From 2012-2015, Dan was Vice President of Oncology for Thermo Fisher Scientific (Life Technologies) where he oversaw the development of cancer sequencing products and pharma companion diagnostic partnerships. From 2006-2012, Dan was co-founder and CEO of Compendia Bioscience, a University of Michigan spin-off formed to further develop and commercialize his thesis project, Oncomine, a cancer genome data-mining platform. Over six years, Compendia grew to 20+ pharma customers and 10,000+ users, culminating in the acquisition by Life Technologies in 2012.

Dan and his family love summers on the lake in Michigan and snow skiing in Park City, Utah.